Dead end for NPY Y5-receptor antagonists?

Nature Reviews Drug Discovery

Volumn 1, Issue 12, 2002, Pages 932-933

  Kirkpatrick, Peter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; ANTIOBESITY AGENT; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; RA 972; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; DIET RESTRICTION; DRUG ACTIVITY; DRUG PENETRATION; DRUG POTENCY; DRUG RESEARCH; DRUG SELECTIVITY; DRUG TARGETING; FEEDING BEHAVIOR; FOOD INTAKE; KNOCKOUT MOUSE; MEDICAL ASSESSMENT; MOUSE; NONHUMAN; NOTE; OBESITY; PREDICTION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION;

EID: 0042446123     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd969     Document Type: Note

References (1)

1. Turnbull, A. V. et al. Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats. Diabetes 51, 2441-2449 (2002)